Uremic pruritus

Kidney International

Volumn 87, Issue 4, 2015, Pages 685-691

  Mettang, Thomas ^a   Kremer, Andreas E ^b  

^a DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Chronic kidney disease; Hemodialysis; Itch; Peritoneal dialysis; Uremic pruritus

Indexed keywords

ANTIINFLAMMATORY AGENT; CALCIUM SALT; EMOLLIENT AGENT; GABAPENTIN; GAMMA LINOLENIC ACID; HISTAMINE; KAPPA OPIATE RECEPTOR AGONIST; MAGNESIUM SALT; MU OPIATE RECEPTOR ANTAGONIST; NALFURAFINE; NALTREXONE; OPIATE RECEPTOR; PARATHYROID HORMONE; PENTOXIFYLLINE; PLACEBO; TACROLIMUS; THALIDOMIDE; 4 AMINOBUTYRIC ACID; AMINE; CALCIUM CHANNEL BLOCKING AGENT; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; KAPPA OPIATE RECEPTOR; MORPHINAN DERIVATIVE; NARCOTIC ANTAGONIST; PREGABALIN; SPIRO COMPOUND;

ACUPUNCTURE; CHRONIC KIDNEY DISEASE ASSOCIATED PRURITUS; CHRONIC KIDNEY DISEASE PRURITUS; DRUG DOSE COMPARISON; END STAGE RENAL DISEASE; GRAFT VERSUS HOST REACTION; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; KIDNEY TRANSPLANTATION; MYELOMA; PATHOGENESIS; PHOTOTHERAPY; PRIORITY JOURNAL; PRURITUS; REVIEW; SYMPTOM; SYSTEMIC THERAPY; TOPICAL TREATMENT; UREMIA; UREMIC PRURITUS; AGONISTS; CHRONIC KIDNEY FAILURE; COMPLICATION;

ACUPUNCTURE THERAPY; AMINES; ANTI-INFLAMMATORY AGENTS; CALCIUM CHANNEL BLOCKERS; CYCLOHEXANECARBOXYLIC ACIDS; GAMMA-AMINOBUTYRIC ACID; GAMMA-LINOLENIC ACID; HUMANS; MORPHINANS; NALTREXONE; NARCOTIC ANTAGONISTS; PENTOXIFYLLINE; PHOTOTHERAPY; PREGABALIN; PRURITUS; RECEPTORS, OPIOID, KAPPA; RENAL INSUFFICIENCY, CHRONIC; SPIRO COMPOUNDS; TACROLIMUS; THALIDOMIDE; UREMIA;

EID: 84926528098     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.454     Document Type: Short Survey

References (45)

1. Pisoni RL, Wikström B, Elder SJ et al. Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2006; 21: 3495-3505.
2. Weisshaar E, Matterne U, Mettang T. How do nephrologists in haemodialysis units consider the symptom of itch? Results of a survey in Germany. Nephrol Dial Transplant 2009; 24: 1328-1330.
3. De Marchi S, Cecchin E, Villalta D et al. Relief of pruritus and decreases in plasma histamine concentrations during erythropoietin therapy in patients with uremia. N Engl J Med 1992; 326: 969-974.
4. Balaskas EV, Uldall RP. Erytropoietin does not improve uremic pruritus. Perit Dial Int 1992; 12: 330-331.
5. Peer G, Kivity S, Agami O et al. Randomised crossover trial of naltrexone in uraemic pruritus. Lancet 1996; 348: 1552-1554.14.
6. Pauli-Magnus C, Mikus G, Alscher DM et al. Naltrexone does not relieve uremic pruritus: results of a randomized, placebo-controlled crossoverstudy. J Am Soc Nephrol 2000; 11: 514-519.
7. Narita I, Alchi B, Omori K et al. Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney Int 2006; 69: 1626-1632.
8. Ponticelli C, Bencini PL. Uremic pruritus: a review. Nephron 1992; 60: 1-5.
9. Gilchrest GA, Stern RS, Steinman TI et al. Clinical features of pruritus among patients undergoing maintenance hemodialysis. Arch Dermatol 1982; 118: 154-156.
10. Mathur VS, Lindberg J, Germain M et al. A longitudinal study of uremic pruritus in hemodialysis patients. Clin J Am Soc Nephrol 2010; 5: 1410-1419.
11. Young AW, Sweeney EW, David DS et al. Dermatologic evaluation of pruritus in patients on hemodialysis. NY St J Med 1973; 73: 2670-2674.
12. Mettang T, Fritz P, Weber J. Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD). The role of plasma histamine and skin mast cells. Clin Neprol 1990; 34: 136-141.
13. Schwab M, Mikus G, Mettang T. Urämischer pruritus im Kindes-und Jugendalter. Monatszeitschrift Kinderheilkunde 1999; 147: 232.
14. Tessari G, Dalle Vedove C, Loschiavo C et al. The impact of pruritus on the quality of life of patients undergoing dialysis: a single centre cohort study. J Nephrol 2009; 22: 241-248.
15. Mettang T, Pauli-Magnus C, Alscher DM. Uraemic pruritus-new perspectives and insights from recent trials. Nephrol Dial Transplant 2002; 17: 1558-1563.
16. Massry S, Popovzer MM, Coburn JM et al. Interactable pruritus as a manifestation of secondary hyperparathyroidism in uremia. N Engl J Med 1968; 279: 697-700.
17. Hampers CL, Katz AI, Wilson RE et al. Disappearence of uremic itching after subtotal parathyreoidectomy. N Engl J Med 1968; 279: 695-697.
18. Stahle-Bäckdahl M, Hägermark O, Lins LE et al. Experimental and immunohistochemical studies on the possible role of parathyroid hormone in uremic pruritus. J Intern Med 1989; 225: 411-415.
19. Stockenhuber F, Kurz RW, Sertl K et al. Increased plasma histamine in uremic pruritus. Clin Sci 1990; 79: 477-482.
20. Weisshaar E, Dunker N, Rö hl FW et al. Antipruritic effects of two different 5-HT3 receptor antagonists and an antihistamine in haemodialysis patients. Exp Dermatol 2004; 13: 298-304.
21. Dugas-Breit S, Schopf P, Dugas M. Baseline serum levels of mast cell tryptase are raised in hemodialysis patients and associated with severity of pruritus. J Dtsch Dermatol Ges 2005; 3: 343-347.
22. Blachley JD, Blankenship DM, Menter A et al. Uremic pruritus: skin divalent ion content and response to ultraviolet phototherapy. Am J Kidney Dis 1985; 5: 237-241.
23. Szepietowski JC, Reich A, Schwartz RA. Uraemic xerosis. Nephrol Dial Transplant 2004; 19: 2709-2712.
24. Virga G, Visentin I, La Milia V et al. Inflammation and pruritus in haemodialysis patients. Nephrol Dial Transplant 2002; 17: 2164-2169.
25. Kimmel M, Alscher DM, Dunst R et al. The role of micro-inflammation in the pathogenesis of uraemic pruritus in haemodialysis patients. Nephrol Dial Transplant 2006; 21: 749-755.
26. Gianni LM, Sulli MM. Topical tacrolimus in the treatment of atopic dermatitis. Ann Pharmacother 2001; 35: 943-946.
27. Pauli-Magnus C, Klumpp S, Alscher D et al. Short-term efficacy of tacrolimus ointment in severe uremic pruritus. Perit Dial Int 2000; 6: 802-803.
28. Kuypers DR, Claes K, Evenepoel P et al. A prospective proof of concept study of the efficacy of tacrolimus ointment on uraemic pruritus (UP) in patients on chronic dialysis therapy. Nephrol Dial Transplant 2004; 19: 1895-1901.
29. Duque MI, Yosipovitch G, Fleischer AB et al. Lack of efficacy of tacrolimus ointment 0.1% for treatment of hemodialysis-related pruritus: a randomized, double-blind vehicle-controlled study. J Am Acad Dermatol 2005; 52: 519-521.
30. Chen YC, Chiu WT, Wu MS. Therapeutic effect of topical gamma-linolenic acid on refractory uremic pruritus. Am J Kidney Dis 2006; 48: 69-76.
31. Gunal AI, Ozalp G, Yoldas TK. Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial. Nephrol Dial Transplant 2004; 19: 3137-3139.
32. Razeghi E, Eskandari D, Ganji MR et al. Gabapentin and uremic pruritus in hemodialysis patients. Ren Fail 2009; 31: 85-90.
33. Rayner H, Baharani J, Smith S et al. Uraemic pruritus: relief of itching by gabapentin and pregabalin. Nephron Clin Pract 2013; 122: 75-79.
34. Wikström B, Gellert R, Ladefoged SD et al. m-Opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies. J Am Soc Nephrol 2005; 16: 3742-3747.
35. Kumagai H, Ebata T, Takamori K. Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a phase III, randomized, double-blind, placebo-cpntrolled study. Nephrol Dial Transplant 2010; 25: 1251-1257.
36. Mettang T, Krumme B, Bohler J et al. Pentoxifylline as treatment for uraemic pruritus-an addition to the weak armentarium for a common clinical symptom? Nephrol Dial Transplant 2007; 22: 2727-2728.
37. Silva SR, Viana PC, Lugon NV et al. Thalidomide for the treatment of uremic pruritus: a crossover randomized double-blind trial. Nephron 1994; 67: 270-273.
38. Gilchrest BA, Rowe JW, Brown RS et al. Ultraviolet phototherapy of uremic pruritus. Long-term results and possible mechanisms of action. Ann Intern Med 1979; 91: 17-21.
39. Tan JKL, Haberman HF, Coldman AJ. Identifying effective treatments for uremic pruritus. J Amer Acad Dermatol 1991; 25: 811-818.
40. Ko MJ, Yang JY, Wu HY et al. Narrowband ultraviolet B phototherapy for patients with refractory uremic pruritus: a randomized controlled trial. Br J Dermatol 2011; 165: 633-639.
41. Duo LJ. Electrical needle therapy of uremic pruritus. Nephron 1987; 47: 179-183.
42. Che-yi C, Wen CW, Min-Tsung K et al. Acupuncture in haemodialysis patients at the Quchi (LI11) acupoint for refractory uraemic pruritus. Nephrol Dial Transplant 2005; 20: 912-915.
43. Manenti L, Tansinda P, Vaglio A. Uraemic pruritus: clinical characteristics, pathophysiology and treatment. Drugs 2009; 69: 251.
44. Altmeyer P, Kachel HG, Schäfer G et al. Normalisierung der urämischen Hautveränderungen nach Nierentransplantation. Hautarzt 1986; 37: 217-221.
45. Staender S, Raap U, Weisshaar E et al. The pathogenesis of pruritus. JDDG 2011; 9: 456-463.